From NCC and its step-down subsidiary OB Infrastructure receiving an order of debarment from the NHAI to Zydus Lifesciences getting final approval from the USFDA for bosentan tablets for oral suspension, these are some of the stocks to watch out ahead of Thursday’s trading session.
